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Abstract
Background: Increasing evidence shows that the cancer microenvironment affects both tumorigenesis and the response of
cancer to drug treatment. Therefore in vitro models that selectively reflect characteristics of the in vivo environment are
greatly needed. Current methods allow us to screen the effect of extrinsic parameters such as matrix composition and to
model the complex and three-dimensional (3D) cancer environment. However, 3D models that reflect characteristics of the
in vivo environment are typically too complex and do not allow the separation of discrete extrinsic parameters.
Methodology/Principal Findings: In this study we used a poly(ethylene glycol) (PEG) hydrogel-based microwell array to
model breast cancer cell behavior in multilayer cell clusters that allows a rigorous control of the environment. The
innovative array fabrication enables different matrix proteins to be integrated into the bottom surface of microwells.
Thereby, extrinsic parameters including dimensionality, type of matrix coating and the extent of cell-cell adhesion could be
independently studied. Our results suggest that cell to matrix interactions and increased cell-cell adhesion, at high cell
density, induce independent effects on the response to Taxol in multilayer breast cancer cell clusters. In addition, comparing
the levels of apoptosis and proliferation revealed that drug resistance mediated by cell-cell adhesion can be related to
altered cell cycle regulation. Conversely, the matrix-dependent response to Taxol did not correlate with proliferation
changes suggesting that cell death inhibition may be responsible for this effect.
Conclusions/Significance: The application of the PEG hydrogel platform provided novel insight into the independent role
of extrinsic parameters controlling drug response. The presented platform may not only become a useful tool for basic
research related to the role of the cancer microenvironment but could also serve as a complementary platform for in vitro
drug development.
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Introduction
Cancer development and progression is often accompanied by
microenvironmental changes that can, in turn, promote (or
prevent) neoplasia [1–5]. Interestingly, the altered microenviron-
ment has not only been shown to promote cancer progression [6]
but also to influence the outcome of treatment. Cell adhesion-
mediated drug resistance (CAM-DR) [7] has a transient effect on
cell behavior induced for example by extracellular matrix (ECM)
signaling. CAM-DR can be primarily attributed to altered cell
cycle regulation and/or integrin-mediated survival [8]. Interest-
ingly, tumor-stroma cooperation occurs during cancer progression
and often induces CAM-DR. To this end, Sherman-Baust et al.
demonstrated that over-expression of collagen IV correlates with
ovarian cancer grade, while adhesion of tumor cells to collagen IV
in vitro mediates CAM-DR [9]. Previous research indicates that a
similar effect occurred in a b1-integrin dependent manner [10,11].
In addition to CAM-DR, the dimensionality of the culture
environment has been shown to play a central role in the outcome
of drug treatment in vitro [12–14]. It is a general observation that
three-dimensional (3D) cell culture, in contrast to two-dimensional
(2D) cell culture, better recapitulates the characteristics of the in
vivo environment [15–17]. In cancer, this deviation can partly be
explained by the high density of the 3D tumor tissue, which largely
affects treatment efficiency by reduced drug penetration over long
diffusion distances [18] and can lead to hypoxic conditions.
However, it is also hypothesized that the 3D organization per se
can alter the cancer cell’s response to apoptotic stimuli [19], even
in the absence of oxygen tension differences [20]. For example, the
3D culture may lead to phenotype changes, such as increased
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levels in cyclin-dependent kinase p27kip1 and decreased prolifer-
ation [13], which could be explained by increased cell-cell
adhesion in 3D [21]. Therefore, we propose that extrinsic
parameters important in drug responses and thereby for the
explanation of the observed differences between in vitro and in vivo
outcomes include, but are not limited to, dimensionality, extent of
cell to cell and cell to matrix interactions and ECM constitution.
The increasing knowledge of the influence of the microenvi-
ronment on cancer progression and drug response has initiated an
interest in drugs which target the microenvironment [22,23,24].
Combinational therapies of traditional chemotherapeutics and
targeting of the tumor-stromal interaction to prevent the influence
of CAM-DR may not only increase the efficiency of classic
therapies but also contribute to the development of a personalized
therapy approach. Together with predictive markers, personalized
therapy may become the future standard decreasing side effects
and increasing efficiency. Specific stromal components are starting
to be considered as clinically relevant in various cancers [5,25–27],
indicating they could be highly potent biomarkers. In this work, we
highlight the need for novel culture models that provide detailed
information on the cancer-microenvironment interaction and pave
the way to improved pre-clinical models.
A range of different models that mimic the 3D tumor
environment have been characterized and regularly used in
academia, and lately some of the strategies are being adapted by
the pharmaceutical industry [28]. Multi-cellular tumor spheroids
have a high complexity and have been shown to recapitulate
several characteristics of a non-vascularized tumor [29]. On the
other hand, 3D protein matrices are superior at mimicking specific
aspects of the cancer cell to ECM interactions, and co-culture
systems may be necessary to study processes such as mammary
tissue morphogenesis [30]. The growth of cells in Matrigel [31],
collagen I [15] or fibronectin-based cell-derived matrices [32] have
been irreplaceable for numerous discoveries related to the
understanding of matrix-dependent cancer progression [5] and
drug response [33]. However, both the spheroids and the 3D
protein matrices represent models in which extrinsic parameters,
such as three-dimensionality, scaffold rigidity and type of protein
coating, cannot be independently controlled. Furthermore, the
cell-driven cluster formation in 3D protein matrices makes it
difficult to spatially and temporarily control cell positioning. This
limits the use of such models in drug development, where
microscopy-based read-outs and high-content screening protocols
are becoming standard [34].
Therefore, protein-coated microwell arrays can serve as an
attractive alternative to standard 3D models, as they permit the
culture of cells in 3D adhesive environments with a high control of
the culture conditions [35]. This enables the study of the role of
different extrinsic parameters, such as dimensionality, matrix
coating and the extent of cell-cell contacts independently of each
other [36,37].
Here we investigate the use of a PEG microwell platform for the
creation of a multilayer cell cluster microarray with tunable 2D
protein coating. By careful selection of extrinsic parameters, a
simplified model of tumorigenic breast cancer was achieved,
encompassing factors such as cell to matrix and multi-cellular cell
to cell interactions. This system enables a high reproducibility in
the cancer model fabrication as well as a high control of discrete
microenvironmental parameters. This characteristic was used to
explore the effect of Taxol against independent extrinsic factors,
such as dimensionality, ECM coating and cell density. Our results
also clarify the relationship between proliferation and drug
response in this context and thereby give some thoughtful
information on proliferation rate, cell to cell and cell to matrix
interactions as predictive factors.
Results
PEG Hydrogel Microwell Arrays as a Platform for High
Content Analysis of Multilayer Cell Clusters
It has been established that the PEG hydrogel microwell array is
a useful tool to expose cells to controlled microenvironments [38].
We wanted to investigate the suitability of this platform for the
formation of confined multilayer clusters to model discrete aspects
of the tumor microenvironment. The PEG hydrogels were
prepared by micromolding the PEG gel precursor and selectively
coating the bottom of the microwells with different ECM proteins
to facilitate cell attachment (Fig. S1A). The successful coating of
the bottom of the microwells with laminin, collagen I and
fibronectin was confirmed by indirect immunofluorescence (see
Fig. S1B).
We tested cluster formation in the ECM-coated arrays by
culturing the well-characterized human breast cancer cell lines
MCF-7 and MDA-MB-231. These cells represent tumorigenic and
tumorigenic/invasive breast cancers, respectively. In both cases,
cells proliferated and formed multilayer clusters in the microwells
within 24 hrs independently of the type of ECM protein coat used
(Fig. S2A). However, MDA-MB-231 cells showed a significantly
greater reduction in proliferation in comparison to growth on
collagen-coated 2D plastic (6866% in comparison to only 4267%
in MCF-7 cells (see Fig. S2B). Thus, changing the dimensionality
of the microenvironment had a greater impact on the proliferation
of MDA-MB-231 cells versus MCF-7 cells. Furthermore, the cell
density observed in multilayer cell clusters formed of MCF-7 cells
was significantly greater in comparison to the density observed in
MDA-MB-231 multilayer cell clusters (39611% greater, p = 0.01)
(Fig. S2C).
Notably, our setup is compatible with conventional inverted
confocal microscopy as the thickness of the hydrogel was
#100 mm and it was molded on a thin support comparable to a
cover glass, thickness No.1.5. Thereby, images with sub-cellular
resolution from within the clusters (Fig. 1A) could be obtained
enabling high content information on the cell state as well as
information of the spatial distribution in three dimensions (Fig. 1B).
Cell to Matrix Interaction Plays a Key Role in the
Multilayer Cell Clusters’ Response to Drug Treatment
The importance of cell to matrix interactions, matrix compo-
sition and the 3D organization of cells in the regulation of drug
response has been highlighted in the literature [11,33]. For this
reason we hypothesized that the controlled environment of the
microwells could be a valuable tool to retrieve more information
on the role of matrix interaction in multilayer cell clusters. In
particular, the platform enabled the study of matrix effects
independently of other factors. Indeed, the initial results showed
that MCF-7 cell clusters representing early breast cancer showed
no matrix-dependent morphology differences between laminin
and collagen I (Fig. 1C). Independently of the protein coating in
the 90 mm wide microwells, clusters were formed with a width
ranging between 80–90 mm. The height of the clusters was
determined to 5663 mm at 48 hr after seeding (Fig. S3). In
controls without matrix coating, the multilayer cell cluster spread
less in the x-y plane and were substantially smaller in size
(diameter ranging between 55–65 mm). This suggests that spread-
ing of multilayer cell cluster was due to the protein coating, and, in
control samples without the protein coating, there was no effective
interaction with the PEG hydrogel (Fig. 1C).
Drug Response in a Breast Cancer Model
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Interestingly, matrix effects, as previously observed in uncon-
fined monolayer cultures, could be reproduced in the multilayer
clusters. After 24 h exposure to 100 nM Taxol, cell death in the
clusters was determined by analysis of nuclear morphology
(Fig. 2A). In collagen I-coated microwells, cell death was
1962% lower (p,0.001) than in wells with laminin coating
(Fig. 2B). These results suggest that the specific interaction with the
mesenchymal protein may impart a Taxol protective or Taxol
resistance effect.
The Effect of the ECM Depends on the Position of the
Cell within the Cluster
To further understand the role of the specific matrix proteins on
Taxol response, we quantified the level of cell death as a function
of the specific cell position within the clusters (i.e. determining the
amount of cell death at the individual image planes z1, z2 and z3,
corresponding to bottom, middle and top sections, respectively).
As expected, the largest difference between collagen I and
laminin occurred at the bottom layers of the clusters where direct
cell to matrix interactions were predominant (Fig. 2C). On
laminin, the drug response increased as the matrix interactions
became more prevalent (1864% increase in cell death from z3 to
z1, p,0.001) while collagen I showed the reverse trend (1962%
decrease in cell death from z3 to z1, p,0.001). The drug response
at plane z1 (bottom) was 3964% higher on laminin compared to
on Collagen I (p,0.001). A smaller difference, but following the
same trend, was observed in image plane z2, in which the cell
death was 1663% higher on laminin (p,0.001). Interestingly, at a
distance of 35 mm away from the matrix interface in the z3 slice,
there was no significant difference in the response to Taxol on
laminin vs. collagen I.
Inhibition of b1-integrin Increases Taxol Response in the
Multilayer Cell Clusters
Previous work has highlighted the importance of integrin b1, i.e.
the two major collagen receptors a1b1 and a1b2 [39], for
proliferation, survival and invasive signaling in breast cancer cells
[32,40,41]. Thus, we decided to explore the role of b1-integrin in
the observed Taxol responses. This was achieved by treating the
cell clusters with the well-characterized monoclonal antibody 13
(mAb13) that binds to integrin-b1 and favors its inactive
conformation [42].
When b1-integrin binding was inhibited in combination with
Taxol treatment, the average cell death was increased by 2165%
(p,0.01) in comparison to controls treated with Taxol and an
unspecific IgG antibody (Fig. 3A). Hence, this data suggests that
the interaction with collagen I induced a protective effect on the
cancer cells reducing their response to Taxol even after 48 hrs
culture. Furthermore, it indicates that b1-integrin plays a major
role in this adhesion-mediated effect. Treatment with mAb13
alone did not lead to a significant increase in apoptosis; cell death
was consistently below 3% during mAb13 treatment (Fig. 3A).
This shows that the combinatorial effect of Taxol treatment and
b1-integrin-blocking was not cumulative but rather synergistic.
Figure 1. Microscopy-based read-out of the clusters in the microwell array. As the cell clusters in the microwell array are aligned in the
same z-plane, confocal imaging can be used to read-out cell behavior. The clusters were imaged at three different topographical planes; z1, z2 and z3
(A). This enables the evaluation of cell behavior at the single cell level and therefore the determination of multiple parameters (B). The lower right
image shows nuclear fragmentation and BrdU incorporation levels within a cluster, which were used to assess apoptosis and proliferation,
respectively, after treatment with taxol. Scale bar is 50 mm. (C) With this platform, cancer cell clusters formed with similar morhology independent of
the protein coating, as shown here for MCF-7 cells on uncoated controls, collagen I and laminin. Note that in the uncoated control wells, multilayer
cell cluster spread to a lesser extent in the x-y plane.
doi:10.1371/journal.pone.0040141.g001
Drug Response in a Breast Cancer Model
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Intriguingly, the effect of b1-integrin blocking varied according to
the position of the cell within the multilayer cluster (Fig. S4).
The effects of b1-integrin blocking on drug response were in
extension correlated to proliferation levels as proliferation rate
closely relates to Taxol response. In fact, mAb13 treatment per se
significantly reduced the average proliferation by 1063%
(p,0.01) (Fig. 3B).
Dimensionality-related Differences in Drug Response are
Markedly Reduced when Cell Density in Mono- and
Multilayer Clusters is Comparable
It has been repeatedly shown that 3D culture reduces the
response to drugs [14]. While many microenvironmental param-
eters may differ substantially in 3D vs. 2D, we decided to use our
controlled model system to elucidate the role of a few defined
parameters. By comparing cells cultured as multilayer cell clusters
in 90 mm wide collagen coated microwells to cells cultured as
monolayer clusters on 200 mm wide collagen patterns, we were
able to assess the roles of cell density and dimensionality
independently of other parameters (Fig. 4A).
In line with previous evidence, we observed that the drug
response was significantly lower in the multilayer cell clusters in
the microwell array compared to cells cultured as unconfined
monolayers on a hydrogel without patterns (4564% and
6362% cell death respectively, p,0.001) (Fig. 4B). Further-
more, it was found that the observed reduced drug response in
the multilayer clusters correlated with a reduction in cell
proliferation (Fig. 4C). Control cells proliferated at a 1064%
lower rate in multilayers compared to in monolayers (p,0.05).
To elucidate the effect of cell density in these differences, we
exploited the natural variation in cell density on circular
collagen-I patterns (Ø = 200 mm) on the microstructured PEG
hydrogel. The confined monolayer clusters allowed us to control
the cell density, i.e. the surface area of contact between
neighboring cells. For analysis of the results, we binned the cell
numbers into four categories ranging from low, sub-confluent
density with ,55 cells per pattern to high cell density with
approximately 100 cells per pattern. Importantly, the cell
number at the highest density was comparable to the cell
density in a multilayer cluster after 48 h culture. Using this
experimental setup, it was found that drug response in the
confined monolayers significantly decreased with increasing cell
density. At the lowest cell density (,55 cells per pattern), the
cell death was 6363%, which is 1164% higher than at a cell
density of 76–96 cells per pattern (p,0.05) (Fig. 4D). At the
highest monolayer cell density, with 97–107 cells per pattern,
i.e. similar to the cell density in the multilayer clusters, the cell
death was slightly, but not significantly, greater than in the
multilayers.
To determine how the observed differences were related to cell
proliferation, we repeated the experiment in the absence of drug
treatment and determined the density-dependence in proliferation.
An effect of cell density on proliferation was first observed at a
density of about 86 cells per pattern (Fig. 4E), where proliferation
decreased by 1264% compared to the lowest cell density
(p,0.05). As could be expected, the proliferation at the highest
cell density with 100 cells per monolayer, which matches the cell
density in the multilayer clusters, was not significantly different to
the proliferation levels observed in the multilayers.
Down-regulation of E-cadherin Increases Proliferation at
High Cell Densities
The effect of cell density on cell behavior could be explained by
several factors such as increased cell-cell contacts and morphology
Figure 2. Matrix-dependent drug response in multilayered cultured cells. Cell death after Taxol treatment was determined by analysis of
nuclear morphology in confocal images. The example images in (A) are representative images of cells in the z2-section stained with propidium iodide
after fixing in methanol. A significantly higher number of fragmented nuclei were observed following Taxol treatment in cell clusters cultured in both
collagen I and laminin-coated microwells. The response to 24 h treatment with 100 nM Taxol in MCF-7 clusters after 24 h cluster formation was
significantly higher in cells cultured in laminin-coated wells compared to cells cultured in microwells coated with collagen I (B). To further understand
the effect of the matrix on drug response, we assessed drug response at different locations within the clusters. The difference between laminin and
collagen I at 24 h was predominant at the two lower z-positions, z1 and z2 (C). Further away from the matrix coating, at the z3 location, the cell death
was not matrix coating-dependent. Scale bar is 50 mm. (*, ** and *** = p,0.05, p,0.01 and p,0.001 respectively, ns = not significant. The grey stars
represent significant differences between z1 and the other image planes for laminin and collagen I respectively. Black stars represent comparisons
between laminin and collagen I).
doi:10.1371/journal.pone.0040141.g002
Figure 3. The effect of blocking b1-integrin on drug response
and proliferation. MCF-7 multilayer clusters cultured in collagen I-
coated microwells were treated with the integrin-blocking antibody
mAb13 and/or Taxol. The percentage of cell death (A) and proliferation
(B) are depicted. Note how mAb13 treatment significantly increased cell
death, while integrin-blocking also affected the proliferation when
compared with IgG controls. (** = p,0.01).
doi:10.1371/journal.pone.0040141.g003
Drug Response in a Breast Cancer Model
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changes of the cell and its nucleus. The results of previous studies
have suggested a correlation between increased E-cadherin,
growth suppression and reduced drug response in 3D cultured
cancer cells [13,21]. To determine the role of E-cadherin in the
cell-density dependent proliferation, we decided to knockdown its
expression.
The down-regulation of E-cadherin levels in the MCF-7 cells by
E-cadherin siRNA reached an efficiency of 80%, as confirmed by
western blot (Fig. 5A). It was found that this down-regulation
caused only a modest effect on the cell morphology of cells
cultured as monolayer clusters on collagen I patterns (Fig. 5B and
C). Following siRNA transfection, cells still grew as colonies with
the individual cells in close contact with one another. However,
staining E-cadherin by indirect immunofluorescent staining
showed clear differences after siRNA treatment. In cells treated
with scramble siRNA (s-control), E-cadherin was clearly present at
high concentrations at cell-cell contacts (Fig. 5B). Conversely, after
exposure to E-cadherin siRNA (s-Ecad), only a homogenous
intracellular background staining was observed (Fig. 5C), probably
representative of the 80% knockdown efficiency.
Interestingly, the down-regulation of E-cadherin levels at high
cell densities caused a significant increase in proliferation (1.6 fold
increase) compared to the s-control (Fig. 5D). The relative
proliferation increase after knockdown at high vs. low density
differed by approximately 30%, which corresponds directly to the
relative difference in proliferation between low and high density
observed in un-transfected cells (Fig. 4E). The tendency for
increased proliferation after knockdown at low cell densities
suggests that E-cadherin plays a role in proliferation at these
densities. Nonetheless, the results also suggest an increased
importance in the effect imparted by E-cadherin expression levels
at high cell densities.
To further explore the correlation between proliferation and cell
density, we examined the effect of changes in cell density in the E-
Figure 4. The role of cell density on drug response in multilayered cell culture. The effect of cell density was determined by comparing
cells at high cell density in multilayer cell clusters to cells cultured at different densities in monolayer clusters. The images in (A) show cells at the
different experimental conditions. To determine proliferation levels the cells were stained with a primary antibody for BrdU incorporation (green) and
their nuclei were counterstained with PI (red). Here, (i) shows cells in 90 mm wide 3D clusters at high density while (ii) and (iii) are cells cultured on the
200 mmwide (A= 36104 mm) 2D patterns at high and low density, respectively. Initially, it was confirmed that the response to treatment with 100 nM
Taxol was significantly lower in the multilayer clusters compared to cells grown on flat hydrogel substrates (B). Similarly proliferation levels, measured
by BrdU incorporation, was lower in the multilayers (C). In the next step, we tested the role of cell density on drug response by culturing cells as
confined monolayers on collagen I patterns. It was found that drug response was significantly reduced with increasing cell density (D) in the
monolayers. When the cell density was matched in the mono- and multilayers, there was only a small difference in drug response which was not
significant. Using the same experimental setup, we found that proliferation in monolayers decreased with increasing cell density (E). A significant
decrease in proliferation compared to a sub-confluent situation was observed at a cell density of 86 cells per pattern. At matching densities in the
mono- and multilayer clusters, there was no significant difference in proliferation. (*, ** and *** = p,0.05, p,0.01 and p,0.001 respectively, ns = not
significant).
doi:10.1371/journal.pone.0040141.g004
Drug Response in a Breast Cancer Model
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cadherin negative cell line, MDA-MB-231. Interestingly, although
the cell density varied substantially in MDA-MB-231 multilayer
clusters, no difference in proliferation was observed (Fig. 5E).
Thus, in the absence of E-cadherin, changes in cell density did not
seem to impact on cell proliferation supporting the role of E-
cadherin in the density dependent effects observed in MCF-7 cells.
Cell Density Variations Could Not Explain the Matrix-
dependent Drug Responses
In the observations depicted above, we confirmed a cell density
dependence in drug response. Therefore, we decided to examine
the variation in cell density in the data obtained for the
investigation of matrix effects. Interestingly, no differences in cell
density were observed at any location within the clusters cultured
on collagen I (Fig. 6A). This indicates that the observed differences
in drug response at the different z-positions (Fig. 2C) were purely
matrix-dependent. In comparison, in the laminin-coated micro-
wells, there was a small difference in cell density between the
bottom image plane (z1) and the other locations. The cell density
was 1361 cells per area at z1, which is 4.561 and 361 cells lower
than at position z3 and z2 respectively (p,0.001) (Fig. 6A).
However, this difference did not correlate with the pattern for the
drug response distribution in the clusters, where the highest values
were obtained in z1 (Fig. 2C). In the clusters of the invasive MDA-
MB-231 cells, there were no significant differences in the cell
density regardless of the cells’ position within the microwell
(Fig. 6B). However, there was a slight, but insignificant, increase in
proliferation at z1 in contact with collagen I (Fig 6C).
Discussion
It is well accepted that the microenvironment plays an important
role in determining the responsiveness of cancer cells to drug
treatment [43,44]. Certain aspects of the microenvironment are key
to this role including the dimensionality, adhesive proteins and cell
morphology. In numerous 3D cell culture models, it has been
observed that cells present in a 3D configuration show lower
response to chemotherapeutics in comparison to cells cultured on
flat (2D) substrates [12–14]. This effect could be linked to reduced
Figure 5. E-cadherin affected cell proliferation but not morphology in MCF-7 cells. E-cadherin knockdown in the MCF-7 cells was
confirmed by western blot (A). GAPDH levels were used to account for differences in total cell numbers between samples. The confocal images show
cells growing on collagen patterns fixed 48 h after knockdown and stained for E-cadherin (green) and cell nuclei (blue). After knockdown of E-
cadherin levels with si-RNA (C), the E-cadherin distribution in the cells was clearly different to cells only treated with s-control (B). Interestingly, when
E-cadherin was depleted from the MCF-7 cells, increased proliferation in the monolayer cell clusters was observed (D). The extent of the effect of the
knockdown was shown to be dependent on the cell density. At low densities, the relative proliferation increase of 1.3 fold compared to si-RNA
control was not significant. Conversely, at high cell densities, the proliferation increased 1.6 fold compared to si-RNA control and was 30% higher
than the proliferation levels at low density. Hence, this data indicates that E-cadherin is responsible for the reduced proliferation observed at high cell
densities. To further confirm this finding, we investigated the behavior of the MDA-MB-231 cells which do not express E-cadherin. Interestingly, we
observed no difference in proliferation in MDA-MB-231 multilayers with different densities (E). (** = p,0.01, ns = not significant).
doi:10.1371/journal.pone.0040141.g005
Drug Response in a Breast Cancer Model
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cell growth [13], phenotype changes such as increased malignant
potential [14] and the limited diffusion of drugs and nutrients [45].
The relationship between E-cadherin, proliferation and cancer drug
response has previously been explored through the study of cells in
spheroids [21]. On the other hand, the effect of different matrix
proteins on drug response has mainly been investigated using 2D
protein-coated substrates [11].
A drawback of the majority of current cancer models is their
inability to independently control the extrinsic parameters of the
microenvironment, either because the parameters are linked or
the model system is too complex. An illustrative example of this
is the matrix-specific morphology changes observed for breast
cancer cells [46]. Therefore, by studying cells on a conventional
2D matrix array, it may be difficult to determine the effect of
the signaling from the matrix independently of other factors. To
this end, the PEG microwell array allows the production of
breast cancer models in which culture parameters can be tightly
controlled. Thereby, the extrinsic parameters could be individ-
ually manipulated to determine their specific effects upon cell
behavior.
The Role of Cell to Matrix Interactions in Drug Responses
within Multilayer Cell Clusters
Initially, we confirmed the formation of multilayer clusters of
both MCF-7 and MDA-MB-231 cells within the microwells.
MCF-7 cells formed clusters with a narrow size distribution,
independent of the protein coating. This is in contrast to previous
studies in more traditional 3D cell culture systems, in which clear
morphological changes with different matrix proteins were
observed [46–48]. This system therefore allowed exploration of
matrix interaction independently of morphological changes, which
is not possible in alternative model systems.
Using a confocal imaging-based readout, it was revealed that
cell response to Taxol was clearly dependent on the localization
(i.e., z-position) of the cells in question within a given cluster. Cells
in contact with collagen I were significantly less responsive to
treatment compared to cells present in areas where cell-cell
contacts were dominant. Since the cell density was consistent
throughout the entire multilayer clusters, we concluded that the
observed effect must be purely matrix dependent. An opposite
drug response pattern was observed in laminin-coated wells,
however the cell density in these clusters did vary, and
consequently it was non-trivial to deconvolve the differential
effects of cell to matrix and cell to cell interactions. From these
results, it can be concluded that the collagen I interaction either
directly or indirectly made the cells less responsive to, or protected
them from, Taxol treatment. This result is in agreement with
observations indicating that breast cancer cells may show reduced
drug response after adhesion to collagen [11,49]. Interestingly, the
collagen-specific reduction in drug response, in comparison to
laminin, supports the idea that cancer progression promotes
higher drug resistance. Collagen I represents a later stage of
tumorigenesis where the basement membrane that traditionally
separates epithelium from mesenchyme has been damaged or
degraded. The reduction in drug response with the z-position in
the laminin clusters could be due to other factors such as enhanced
cell to cell interactions in the middle of the cluster and lack of
specific integrin engagements in the absence of collagen I. On the
contrary, MDA-MB-231 cells cultured as multilayer clusters in
collagen-coated microwells showed a tendency for higher prolif-
eration at the interface with the protein in a density-independent
manner. This could be explained by the proliferation-promoting
effect of collagen I [48]. Hence, the strong effect of dimensionality
on proliferation in these cells could be interpreted as a lack of
matrix adhesion in the multilayers in comparison to monolayer
cultures.
The contribution of b1-integrins on the collagen I-dependent
effects was confirmed, as blocking this interaction led to a major
increase in drug response. This observation correlates with work
by Aoudjit, et al., who showed that collagen I-dependent drug
response could be related to the collagen I-specific integrin
heterodimer a2b1 [11], as well as with our own work, which
highlighted the contribution of b1-integrin to cancerous behavior
[32,33,50]. Interestingly, blocking the b1-integrin also induced
reduced cell proliferation indicating an inverse relationship
between proliferation and drug response. This last point may be
considered important in the study of drug efficacies in cancer,
especially in cancer instigating cells, e.g., cancer stem cells that are
known for their self renewal capabilities, their strong dependency
on a physical ECM containing niche, as well as for their low
proliferative rates [51].
The Role of Cell Density in the Drug Response in
Multilayer Cell Clusters
In a central experiment, the new platform was used to study the
importance of cell density in dimensionality-dependent drug
response. Initially, it was shown that cells in the multilayer clusters
were less susceptible to Taxol and demonstrated a reduced
proliferation compared to cells cultured as monolayers. Using
collagen-patterns with cells at increasing densities, it was found
that drug response was clearly density dependent. Furthermore,
this data indicates that the increased cell density in the multilayers
could largely explain the dimensionality effect typically observed in
3D cultures.
Figure 6. The role of cell density in the matrix-dependent drug response. Cell density was predominately unaffected by either matrix
coating or the cell’s position within the multilayer clusters (A). The only observed difference was a slightly lower cell density in z1 for clusters growing
on laminin. Hence, any effect of matrix coating could be expected to be independent of cell density. In MDA-MB-231 clusters, there was little variation
in the cell density regardless of the z position in the (B). However, a trend towards higher proliferation at the interface with the matrix was observed
but not statistically confirmed (C). (MUCL = multilayer cell cluster, ** and *** = p,0.01 and p,0.001 respectively, ns = not significant. Grey symbols
in A represents the comparison to z1).
doi:10.1371/journal.pone.0040141.g006
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Interestingly, the reduced proliferation rate observed at
increased cell density in the monolayers closely approached the
low values seen in multilayer clusters. Therefore, it can be
concluded that the main reason for a ‘three-dimensionality’ effect
in these models of reduced complexity was the increased cell to cell
interactions together with a reduced proliferation seen at high cell
densities (i.e., both in multilayer cell cluster and highly dense 2D
monolayer cell cluster). The knockdown of E-cadherin expression
confirmed that the reduced proliferation at high cell densities was
tightly linked to the levels of cell to cell interactions. The key role
of E-cadherin in this effect is further supported by the absence of
cell density effects on proliferation in multilayer clusters formed by
the E-cadherin negative cell line MDA-MB-231. It has been
previously demonstrated that E-cadherin and growth factor levels
are the main determinants of growth, above cell morphology and
size, using the controlled culture of normal epithelial cells [52].
The effect of E-cadherin in some cancers has been shown by
transfection of E-cadherin and applying E-cadherin neutralizing
antibodies to disrupt cell adhesion [21]. However, these methods
also affected the global cell morphology. To our best knowledge,
this is the first study which shows that in a controlled cancer model
E-cadherin-mediated cell-cell adhesion alone is a major factor
contributing to the reduced Taxol susceptibility in 3D.
The Advantage of Controlled Model Systems
The application of the PEG microarray platform for the
exploration of the exact role of different extrinsic parameters on
drug response demonstrated the advantage of controlled model
systems. Clusters within microwells formed and showed no
apparent morphological differences due to the types of matrix
proteins being used. Therefore, this system enabled the study of
matrix-dependent cell behavior independently of parameters such
as cell morphology, contact area with the ECM, etc. Also,
retaining the spatial location of the cell within the cluster allowed
the inter-relationship between cell to matrix vs. cell to cell
interactions to be explored within a simplified 3D environment.
Finally, the ability to control cell densities enabled us to reveal the
role that cell density plays in ‘‘three-dimensionality’’-dependent
effects, as well as the contribution of E-cadherin. The use of this
model system enabled us to confirm previously published studies,
which demonstrated that proliferation and drug response were
reduced in the presence of collagen I or E-cadherin interactions
[11,21,49], thus validating the use of this platform. Furthermore,
the exploitation of the model system permitted us to gain novel
insights into the differential effects of cadherin and integrin based
adhesions. Therefore, we propose that culturing cells with the
possibility of imparting a high level of control of individual
extrinsic parameters will facilitate the discovery of key signaling
mechanisms responsible for the regulation of the distinctive aspects
of the microenvironmental milieu. Furthermore, important inter-
relationships between extrinsic parameters may be determined. In
future work it would be interesting to use this platform to explore
in greater detail the adhesions formed within the multilayer cell
clusters and furthermore determine the inter-relationships between
integrin and cadherin based signaling and its impact on specific
drug responses. Therefore, it is possible that this type of model will
complement additional models, such as cancer spheroids or more
complex models including organotypic 3D culture systems
(amongst others) and animal models, in basic and pre-clinical
cancer research.
Proliferation as a Predictor of Treatment Outcome
In this paper we have presented a study of the combinatorial
effect of Taxol treatment and different extrinsic parameters on
drug response and proliferation. Hence, the role of proliferation in
the effect of certain extrinsic parameters could also be determined.
Firstly, it was shown that both proliferation and drug response
decreased when cells were cultured as multilayer clusters. This
indicates that there was a direct relationship between the effect of
the 3D culture on drug response and proliferation. Similarly,
increased cell density also resulted in a decrease in both drug
response and proliferation. Although the absolute differences in
drug response and proliferation were different, the relative values
were in the same range, i.e., the 1.4 fold increase in drug response
in 2D vs. 3D correlated with a 1.3 fold increase in proliferation.
This fact suggests that both three-dimensionality and cell density
affect drug responses predominantly through alterations in the
regulation of the cell cycle. Interestingly, previous research has
shown that increased cell-cell adhesion in multicellular spheroids
affects cell cycle regulation by increased levels of cyclin dependent
kinase inhibitor p27 [13].
In contrast, interfering with matrix adhesion by blocking b1-
integrin function was shown to increase drug response, while it
induced a reduction in proliferation. This inverse relationship
revealed that the effect of matrix adhesion on drug response was
not proliferation-dependent but may instead be attributed to cell
death signaling downstream of integrin ligation. Matrix adhesion is
not only known to cause increased cell cycle progression [39] but
also anti-apoptosis signaling. Indeed, adhesion-mediated increase
of Akt (serine/threonine Kinase) phosphorylation has been shown
to reduce the apoptosis levels induced by drug treatment
[11,53,54].
The study of the relationship between proliferation and drug
response provides intriguing insights into the signaling pathways
occurring in different microenvironmental settings. These results
could be of interest for the development of new treatment
prediction methods. The pharmaceutical industry is shifting
towards personalized treatment, as it is forecasted to greatly
increase efficiency. To enable the implementation of personalized
therapy, reliable biomarkers are needed [55]. Proliferation index is
one phenotype-related marker that has been highlighted as a
possible predictor. Many anti-cancer drugs are most effective in
proliferating cells, where the contrasting example are dormant
cells, and in cancer instigating cells, which may survive cytotoxic
treatment [56] and form micro-metastases years later. However, it
has been shown that proliferation values cannot always predict the
response to chemotherapeutics [57,58]. One explanation for this
inconsistency could be the effect of microenvironmental param-
eters with multivariate influence on signaling pathways in cell
growth and survival as highlighted by our results. Therefore,
although proliferation index can be useful, the combination with
another marker will probably give a better prediction of drug
response [10]. E-cadherin is known to play an important role in
cancer, and its down regulation is associated with increased
invasiveness. In this paper we show that E-cadherin levels directly
correspond to cell proliferation and drug response in breast
cancer. Therefore, combining E-cadherin-levels with proliferation
index should give enforced strength to the predictive value of
proliferation index. On the other hand, our work shows an inverse
relationship between proliferation and drug response with integrin
activation. Therefore, specific integrin expressions could also
constitute putative complementary markers to proliferation.
Conclusions
In summary, this work showed that a microwell array based on
a PEG hydrogel could be used to create a model of early cancer.
In this model, several parameters of the tumor microenvironment,
including matrix interface and cell-cell contacts, could be
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controlled. By the use of confocal imaging and sub-cellular
resolution, drug response could be determined and correlated with
the spatial location of the cell within clusters in the microarray.
Therefore, it was possible to differentiate between cells in contact
with predominately the ECM or with other cells.
With this model we could observe that matrix-induced drug
response plays an important role in multilayered cells. In addition,
it was confirmed that this effect was independent of other
parameters, such as cell morphology and density. On the other
hand, cell density was shown to be an additional and independent
determinant of drug response. Studying different cell densities in
monolayer cell clusters revealed that cell density was largely
responsible for the effect multilayered cell culture had on both
drug response and proliferation. A direct relationship between
drug response and proliferation with cell density changes was
observed, which could be correlated to increased E-cadherin levels
at higher cell density. On the contrary, this was not observed for
matrix dependent changes of drug response. These results indicate
that both cell cycle regulation and cell death signaling are involved
in determining the drug response in this model of early breast
cancer.
Perhaps the most important conclusion of this study is that
relatively simple models, like the one presented herein, could serve
as complementary tools for pre-clinical development as physio-
logically relevant models that deliver clear results with high
reproducibility.
Materials and Methods
Materials and Cells
The poly(ethylene glycol) (PEG) polymers PEG-vinyl sulfone
(VS) and PEG-thiol (SH) were both from the lab of Matthias
Lu¨tolf, EPFL, Switzerland. Tissue culture treated m-Slide 8-well
dishes were purchased from Ibidi, Germany. Collagen I was
purchased from Gibco, Switzerland. Laminin was obtained from
Sigma, Germany and labeled with a maleimide-PEG-N-hydro-
xysuccinimide ester (JenKem Tech, USA) before use. The protein
solutions were diluted to a working concentration of 300 mg/ml in
PBS before use.
MCF-7 and MDA-MB-231 cells were purchased from the
American Type Culture Collection (ATCC, Manassas, VA, USA).
Dulbecco’s modified Eagle’s medium (DMEM) cell culture media,
penicillin/streptomycin and FBS were all obtained from Invitro-
gen, Switzerland. Taxol was purchased in 1 mg aliquots from
Sigma Aldrich and stored as 1 mM stock solutions in DMSO at
220uC. The mAb13 b1-integrin blocking antibody was a kind gift
from Kenneth Yamada, NIH/NIDCR, Bethesda, MD. The
engineered silencer nucleic acids (s-2769 and s-control) for the
E-cadherin knockdown experiment were from Ambion, USA.
Fabrication of the PEG Microwell Arrays
Microwell arrays were produced at the bottom of 8-well Ibidi
dishes by micromolding as described previously [38]. In short, the
microwell arrays were prepared by molding the PEG hydrogel on
a poly(dimethylsiloxane) (PDMS) mold. To create protein coatings
only at the bottom of the microwells, protein was printed onto the
top of a microstructured PDMS mold using a wet microcontact
printing process as described in [37] (Fig. S1A). Briefly, 200 ml of a
protein solution (0.3 mg/ml) was placed on top of a flat
polyacrylamide hydrogel. After drying, the protein-coated gel
was placed in close contact with the PDMS mold to allow protein
transfer. The types of matrices used (i.e., collagen I, fibronectin or
laminin) were incorporated into the PEG hydrogel using two
different strategies. Collagen I and laminin were especially used in
this study. The large collagen molecule was applied unmodified
and it incorporated into the gel by polymerization during the gel
molding step. Both laminin and fibronectin was first conjugated to
a PEG-malemide linker to allow sufficient attachment to the gel
via covalent linkage.
The PEG hydrogel was prepared by combining PEG-vinyl
sulfone (5% (w/v)) and PEG-thiol (5% (w/v)) to obtain a
stoichoimetric ratio of 1:1. Within a few minutes after mixing,
the polymer solution (10–15 ml) was pipetted onto the micro-
structured PDMS stamp. Finally, the gel was molded between the
PDMS stamp and the polystyrene surface of an Ibidi dish.
Polymerization was achieved within 45–60 min at RT. After-
wards, the Ibidi dish was carefully removed and the arrays were
covered with PBS and stored at 4uC until required. Before usage,
the arrays were sterilized with UV light and incubated with PLL-g-
PEG (200 mg/ml in PBS for 1 h) to render the tissue culture-
treated (poly)styrene surface surrounding the gel non-adhesive for
proteins and cells [59].
Assessing the Role of Matrix Coating
The PEG microwell arrays were prepared the day before cell
seeding. Multilayer clusters were formed by seeding cells into
arrays containing circular microwells 90 mm in diameter and
80 mm deep coated with either collagen I or laminin. MCF-7 (or
MDA-MB-231, see text for details) cells were seeded into the
microwells at a seeding density of 1.5 6 105 cells per Ibidi dish
well. After 3–4 hrs, cells that had not entered the wells were
removed from the plateau surface by two rinsing steps.
To determine the sensitivity to Taxol, cell clusters were treated
with 100 nM Taxol (or 0.01% DMSO (v/v) in the controls) 24 hrs
after seeding. After an additional 24 hrs incubation period, cells
were fixed with ice-cold methanol (70% (v/v) in PBS for 20 min),
rinsed with PBS twice and stained with propidium iodide by
incubation in PI/RNAse staining buffer (undiluted for 30 min at
RT; BD Biosciences, Switzerland). The drug response levels were
determined as the number of fragmented cell nuclei versus total
nuclei.
Assessing the Role of b1-integrin
The clusters were formed in the microwells as described above.
To optimize seeding, we centrifuged the cells (76104 cells per
Ibidi dish well) at 1000 rpm into the microwells. To assess the role
of b1-integrin function in the reduced drug response on collagen I,
we used the well-characterized monoclonal antibody 13 (mAb13)
that binds to b1-integrin and favors its inactive conformation [42].
The mAb13 antibody was added 24 hrs after cluster formation at
a concentration of 50 mg/ml. Following 24 hrs culture in the
presence of the antibody, cells were either assessed for proliferation
or treated for an additional 24 hrs with a mixture of 50 mg/ml
mAb13 and 100 nM Taxol or mAb13 alone, while control
samples lacked either taxol, mAb13 or both reagents.
Assessing the Role of Cell Density and E-cadherin
The multilayer clusters were formed in the microwells as
described above. To create monolayer cell clusters on protein
islands, we seeded 2 6 104 cells per array with 200 mm wide,
collagen I-coated microwells. After centrifugation, this density
resulted in patterns with varying cell density, from very low to
confluent, as confirmed by confocal microscopy. After 48 hrs
culture in 2D or 3D, the cells were either assessed for proliferation
or treated for an additional 24 hrs with 100 nM Taxol.
To modulate cell to cell interactions, E-cadherin expression in
MCF-7 cells was knocked down by transfection with E-cadherin si-
RNA. Lipofectamine-2000 (Invitrogen) was mixed with Opti-Mem
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(1:150, 5 min at RT, Invitrogen) and subsequently combined with
E-cadherin si-RNA (or scrambled control) and incubated for
15 min before addition to the cells. Cells were transfected by
reverse transfection, in which transfection reagents and si-RNA
are added to cells in suspension before seeding onto substrates.
The final concentration of cells was 76104 cells per 300 ml cell
culture media and 100 ml Optimem. The final concentration of
Lipofectamine and si-RNA was 1:1200 and 20 nM respectively.
The samples were incubated for 24 hrs with transfection media.
After an additional growth period of 24 hrs in normal culture
media, the cells were assessed for proliferation or treated for 24 hrs
with 100 nM Taxol.
To stain for E-cadherin, cell samples were first fixed with PBS
containing 3% paraformaldehyde (w/v) for 10 min and subse-
quently permeabilized with Triton-X 100 (0.1% (v/v), 10 min).
Before adding the primary antibodies, samples were rinsed twice
with PBS and blocked with 1% BSA for 30 min. Subsequently,
samples were incubated with primary anti-E-cadherin antibody
(1:100, BD Biosciences) overnight at 4uC. After rinsing, the
samples were incubated with secondary Alexa-Fluor 488-conju-
gated anti-mouse antibody (1:500, 1 h at RT) and counterstained
with Hoechst 33342 (1:3000, 1h RT) before a final rinse and
imaging.
Determining Proliferation by BrdU Incorporation
Proliferation was assessed using the BrdU assay as described
previously [35]. Following an overnight incubation period, the
media was exchanged for media containing 10 mM BrdU (Sigma
Aldrich, Switzerland) and the samples were incubated at 37uC for
an additional 6 hrs; subsequently all the samples were fixed with
ice-cold methanol (70% (v/v) in PBS for 20 min). The samples
were treated with 2 M HCl for 20 min, neutralized with 0.1 M
Borax for 2 min and permeabilized with 0.1% (v/v) Triton-X for
10 min. Samples were labeled with primary mouse-anti-BrdU IgG
(1:100 (v/v); 60 min; BD Biosciences), washed three times with
PBS and incubated with goat anti-mouse IgG Alexa Fluor 488
(1:400 (v/v); 60 min; Molecular Probes). 0.5% (w/v) BSA was
included in all staining buffers to avoid non-specific binding. The
samples were counterstained with PI/RNAse buffer (undiluted,
30 min), to label cell nuclei, and imaged using confocal
microscopy as described above. BrdU-labeled versus PI-labeled
nuclei were manually counted. All stages following fixation were
performed at room temperature.
Imaging of Single Cells in Multilayer Cell Clusters
Confocal microscopy was employed to allow imaging of the
clustered cells with single cell resolution. Two confocal micro-
scopes containing water immersion objectives were used: a Leica
SP2-AOBS CLSM (Leica, Germany) with a 620 objective,
NA = 0.7 and an Olympus FV microscope (Olympus, Japan) with
a640 objective, NA = 0.9. To acquire information from different
positions within the cell clusters with restrained experimental
variability, three individual z-sections were acquired per cell
cluster in all experiments; z1, z2 and z3, where z1 represented the
cells in direct contact with the matrix (i.e., bottom location). The z-
image planes were separated by ,15 mm to avoid overlapping
assessments (Fig. 1A).
Statistic Analysis
All experiments were performed in duplicates and repeated
three times. Quantitative data was plotted as the mean6 standard
error of the mean (SEM). Statistical analysis was performed using
Student’s unpaired two-way t-tests. Differences were considered to
be statistically significant when p,0.05.
Supporting Information
Figure S1 Fabrication of the protein-coated microwell
arrays. A) A PDMS master is molded on a Si-wafer with SU8
microstructures (i). In the next step, this master is coated with
matrix coating at the top of the pillars (ii). A wet microcontact
printing method is used to obtain a reliable protein transfer. The
protein of choice is dried on top of a polyacrylamide gel, and then
this gel is placed upside down on the PDMS master. Finally a
small volume of PEG-gel precursor is placed on the PDMS master
and molded into a thin film between the PDMS master and the
TCP substrate (iii). Upon removal from the PDMS master, the gel
will stick to the TCP surface and hence make up a suitable cell
culture substrate (iv). B) The protein coating is visualized by
indirect fluorescence for Fn, Lam and Col-I. Lam and Col-I are
stained with respective primary antibodies and visualized by
secondary antibody staining using an Ab-Alexa Fluor 488
conjugate while the Fn-coating was visualized by immobilizing
Fn directly conjugated to Alexa Fluor 488.
(TIF)
Figure S2 Cell density and proliferation in the micro-
wells for MDA-MB-231 and MCF-7. We found significant
differences in growth behavior and in the packing density when
the two examined cell lines MCF-7 and MDA-MB-231 were
grown in 90 mm wide collagen I-coated microwells (A). The
images show cell nuclei stained with propidium iodide (red) and
antibody for BrdU incorporation indicating DNA synthesis (green)
(MUCL = multilayer cell cluster). After 72 h culture of these
cancer cells in microwells, proliferation was reduced in compar-
ison to on collagen I-coated TCPS. The effect was significantly
greater in the MDA-MB-231 cells (B). At this point the cells in the
MCF-7 clusters were significantly denser than the cells in the
MDA-MB-231 clusters (C). (* = p,0.05).
(TIF)
Figure S3 Microscopy-based read-out of experiments in
the cell cluster microarray. MCF-7 cells seeded into the
microwell array form clusters with a narrow size distribution.
Because clusters are aligned in the same z-plane, the imaging can
be performed in an automated manner. The width of the MCF-7
multilayered cell clusters was found to be 80–90 mm and 45–
50 mm for wells with a diameter of 90 and 50 mm respectively. The
height of the clusters could be tuned by seeding conditions and
culture time. To measure cluster heights, we stained the cells’ actin
cytoskeleton using fluorescently pre-labeled phalloidin and ana-
lyzed the average cluster heights by means of confocal microscopy.
Results suggested an average height of 5663 mm at 48 hr after
seeding 1.56105 cells onto arrays of microwells with a diameter of
90 mm. The thin hydrogel allowed us to use confocal imaging,
collecting information at three different image planes; z1, z2 and
z3. This enabled evaluation of cell behaviour at the single cell
level. The lower right image shows nuclear fragmentation within a
cluster, which was used to read out apoptosis after treatment with
Taxol. Scale bar is 50 mm.
(TIF)
Figure S4 The effect of blocking b1-integrin at different
positions within the multilayer clusters. Blocking integrin
b1 has a strong effect on drug response, but this effect was only
significant in the two image planes closest to the collagen I coating
(A). The treatment also affected proliferation. The z-plot revealed
that the effect was greatest in image planes z1 and z2, while there
was no significant difference in proliferation at the z3 location (B).
Furthermore, it could be confirmed that these effects were
independent of cell density, as no significant differences in cell
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density between image planes were observed following b1-integrin
inhibition (C). (* and *** represent p,0.05 and p,0.001
respectively, n.s. = not significant).
(TIF)
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